← FDA Drug Approvals (Drugs@FDA)

LEVETIRACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: KNACK · Approved 2025-12-02

Drug application

FDA Application #
ANDA215465
Application type
Abbreviated New Drug Application (Generic)
Brand name
LEVETIRACETAM
Generic name
Levetiracetam
Active ingredients
LEVETIRACETAM
Dosage form
INJECTABLE
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
KNACK
First approval
2025-12-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown